Impact of calcineurin inhibitor-free immunosuppression on de novo donor-specific antibody formation in liver transplant recipients.

Magdalena MeszarosValérie DuboisNicolas Congy-JolivetSarah HamadaCéline TheveninStephanie FaureOlivier BoillotNassim KamarGeorges-Philippe PageauxArnaud Del BelloJérôme Dumortier

Published in: Liver international : official journal of the International Association for the Study of the Liver (2022)

Patients on a CNI-free IS regimen have a higher prevalence of dnDSA than patients on a standard IS regimen. dnDSAs but not CNI-free immunosuppression were associated with abnormal allograft histology.

Keyphrases

end stage renal disease
ejection fraction
risk factors